The Food and Drug Administration (FDA) recently announced plans to require tobacco companies to cut the amount of nicotine in traditional cigarettes. It also announced a ban of Juul e-cigarettes in the U.S., saying the company ...
Jul 20, 2022
0
44
Nurses have experienced higher levels of burnout and associated mental health risks since the beginning of the COVID-19 pandemic, according to a study by graduate researchers in the Department of Psychology at The University ...
May 19, 2022
0
1
A University of Texas at Arlington faculty member and nurse practitioner (NP) said she hopes to bring more attention to an underrecognized condition.
Apr 4, 2022
0
6
To prevent diabetic foot ulcers, research scientists at The University of Texas at Arlington have developed footwear technology that relieves pressure on areas of the feet that experience high stress during walking and other ...
Mar 31, 2022
0
2
When an individual suffers from cancer, the process of programmed cell death called apoptosis does not occur normally, permitting abnormal cells to thrive.
Jan 11, 2022
0
69
Experts predict that without intervention, the problem of multidrug-resistant bacterial infections could be catastrophic by 2050, killing nearly 10 million people each year.
Nov 24, 2021
0
10
In a new research article published in Cancer, University of Texas at Arlington researcher and Assistant Professor Yue Liao in the Department of Kinesiology found that cancer survivors improved their quality of life, physical ...
Nov 12, 2021
0
1
For individuals to sustain their attention on a task over a long period of time, goal-setting is effective but receiving feedback produces a much stronger effect, according to a new study from The University of Texas at Arlington.
Oct 28, 2021
0
19
Bioengineers and scientists at The University of Texas at Arlington, in collaboration with Austin's Shani Biotechnologies, LLC, have developed a new noninvasive technology that may help real-time monitoring of key blood parameters, ...
Oct 28, 2021
0
14
Wei Chen, professor of physics at The University of Texas at Arlington, is the senior author of two papers detailing the effects of copper cysteamine, a next-generation cancer photodrug invented in Chen's laboratory.
Oct 1, 2021
0
36
